RSS   Newsletter   Contact   Advertise with us
Post Online Media

Epizyme appoints Kevin Conroy to board

EpizymeEpizyme, a clinical stage biopharmaceutical company, announced that it has elected Kevin Conroy, chairman and chief executive officer of Exact Sciences to its board of directors.

Mr. Conroy has served as chief executive officer of Exact Sciences since 2009. He served in multiple executive leadership positions at Third Wave Technologies from 2004 to 2008, most recently as president and chief executive officer.

READ MORE Epizyme appoints Robert Bazemore as president and CEO

Prior to Third Wave, Mr. Conroy served as intellectual property counsel at GE Healthcare.

Before joining GE, he served as chief operating officer of two early-stage venture-based technology companies in Northern California.

Prior to those positions, he was an intellectual property litigator at two Chicago law firms, McDermott Will & Emery and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner.

He has served as a director of Third Wave Technologies Inc., since 2005.

Mr. Conroy earned his B.S. in electrical engineering at Michigan State University and his J.D. from the University of Michigan Law School.




What to read next



 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy